Invention Grant
- Patent Title: Compositions and uses thereof for treating disease or condition
-
Application No.: US15733838Application Date: 2019-05-31
-
Publication No.: US11987629B2Publication Date: 2024-05-21
- Inventor: Lieping Chen , Liqun Luo
- Applicant: Tayu Huaxia Biotech Medical Group Co., LTD
- Applicant Address: CN Beijing
- Assignee: Tayu Huaxia Biotech Medical Group Co., Ltd.
- Current Assignee: Tayu Huaxia Biotech Medical Group Co., Ltd.
- Current Assignee Address: CN Beijing
- Agency: MORRISON & FOERSTER LLP
- Priority: WO TCN2018089672 2018.06.01 WO TCN2018099556 2018.08.09
- International Application: PCT/CN2019/089606 2019.05.31
- International Announcement: WO2019/228514A 2019.12.05
- Date entered country: 2020-11-30
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K9/19 ; A61K39/00 ; A61K45/06 ; A61P35/00
Abstract:
The present application provides methods, imaging agents and kits for determination of the distribution and expression levels of an immune checkpoint ligand (such as PD-L1 or a PD-L1 like ligand) in an individual having a disease or condition. Anti-PD-L1 antibody agents, and methods for treating diseases or disorders by administering anti-PD-L1 antibody agents are also provided.
Public/Granted literature
- US20210214444A1 COMPOSITIONS AND USES THEREOF FOR TREATING DISEASE OR CONDITION Public/Granted day:2021-07-15
Information query
